FLIP anticorps (N-Term)
Aperçu rapide pour FLIP anticorps (N-Term) (ABIN925984)
Antigène
Voir toutes FLIP (CFLAR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Souris, Rat (Rattus), Porc, Boeuf (Vache), Chien
-
Immunogène
- CFLAR antibody was raised in rabbit using the N terminal of CFLAR as the immunogen
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CFLAR Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CFLAR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))
-
Autre désignation
- CFLAR
-
Sujet
- CFLAR might contribute to the carcinogenesis and aggressiveness of endometrial carcinoma and might be a useful prognostic factor in the tumor. CFLAR is specially overexpressed in colon cancers and it might contribute to carcinogenesis of normal colonic mucosa. Synonyms: Polyclonal CFLAR antibody, Anti-CFLAR antibody, CASP8 and FADD-like apoptosis regulator antibody.
-
Pathways
- Apoptose, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-